Status:
COMPLETED
Nuclear Morphology of Breast Cells in Ductal Lavage
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Wayne State University
Conditions:
Benign Breast Disease
Eligibility:
FEMALE
18+ years
Brief Summary
Breast nipple aspirate fluids (NAF) are useful for non-invasive monitoring of the breast. NAF has been shown to exhibit large inter-individual differences in lipid peroxidation. Unfortunately, the yie...
Detailed Description
WHY THE STUDY IS BEING DONE Breast nipple aspirate fluids (NAF) can be obtained non-invasively from women, making analyses of this fluid relevant to studies of breast cancer risk. The inter-individua...
Eligibility Criteria
Inclusion
- Age 18 and older
- A diagnosis of proliferative breast disease
- At least 1 month post biopsy
- At least 3 months post any therapy such as tamoxifen
- Good general health
- Sign Consent Form.
Exclusion
- Pregnant or lactating (lactation must have stopped at least 3 months prior)
- Taking coumadin
- Any diseases including cardiovascular, high blood pressure and diabetes
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00259597
Start Date
June 1 2004
End Date
June 1 2007
Last Update
December 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karmanos Cancer Institute
Detroit, Michigan, United States, 48201